scholarly journals Efficacy and Safety of Tralokinumab Plus Concomitant Topical Corticosteroids (TCS) in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results from the 32-Week, Phase 3 ECZTRA 3 Trial

2020 ◽  
Vol 4 (6) ◽  
pp. s102
Author(s):  
Stephan Weidinger ◽  
Jonathan Silverberg ◽  
Darryl Toth ◽  
Thomas Bieber ◽  
Andrew Alexis ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Adult Patients ◽  
Severe Atopic Dermatitis ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Topical Corticosteroids

Abstract not available.

scholarly journals Efficacy and Safety of Tralokinumab Monotherapy in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results from Two 52-Week, Phase 3 Trials (ECZTRA 1 and ECZTRA 2)

2020 ◽  
Vol 4 (6) ◽  
pp. s96
Author(s):  
Eric Simpson ◽  
Andrew Blauvelt ◽  
Emma Guttman-Yassky ◽  
Margitta Worm ◽  
Charles Lynde ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Adult Patients ◽  
Severe Atopic Dermatitis ◽  
Efficacy And Safety ◽  
Phase 3

Abstract not available.

scholarly journals Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis

2020 ◽  
Vol 156 (12) ◽  
pp. 1333 ◽  
Author(s):  
Kristian Reich ◽  
Kenji Kabashima ◽  
Ketty Peris ◽  
Jonathan I. Silverberg ◽  
Lawrence F. Eichenfield ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Severe Atopic Dermatitis ◽  
Efficacy And Safety ◽  
Topical Corticosteroids
Sign in / Sign up

Export Citation Format

Share Document